A Phase 1/2 Study of Durvalumab and Monalizumab in Adult Subjects with Select Advanced Solid Tumors

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: MDF/53908/DEF-2019-172472(v1)
(ERM Project ID: 53908)
NMA SSA Reference Number: SSA/53908/MonH-2019-176189(v1)
Monash Health Ref: RES-19-0000-414X

StatusFinished
Effective start/end date1/07/19 → 30/06/24

Keywords

  • Clinical trial
  • treatment efficacy
  • solid tumours